Royalty Pharma (RPRX)
(Real Time Quote from BATS)
$26.74 USD
+0.30 (1.14%)
Updated Aug 13, 2024 10:54 AM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | 0.92 |
EPS Last Quarter | 0.96 |
Last EPS Surprise | 1.05% |
ABR | 1.50 |
Earnings ESP
|
0.54% |
---|---|
Current Year | 4.00 |
Next Year | 4.33 |
EPS (TTM) | 3.88 |
P/E (F1) | 6.61 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 670.03M | 694.56M | 2.71B | 2.92B |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 671.79M | 695.07M | 2.74B | 2.98B |
Low Estimate | 668.27M | 694.05M | 2.67B | 2.86B |
Year ago Sales | 637.00M | 736.00M | 3.05B | 2.71B |
Year over Year Growth Est. | 5.19% | -5.63% | -11.27% | 7.86% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.92 | 1.09 | 4.00 | 4.33 |
# of Estimates | 3 | 2 | 4 | 4 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.94 | 1.10 | 4.13 | 4.70 |
Low Estimate | 0.91 | 1.08 | 3.89 | 4.02 |
Year ago EPS | 0.79 | 1.15 | 4.49 | 4.00 |
Year over Year Growth Est. | 16.46% | -5.22% | -10.91% | 8.06% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 1 | 2 |
Down Last 30 Days | 0 | 0 | 2 | 3 |
Down Last 60 Days | 0 | 0 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.92 | 1.09 | 4.00 | 4.33 |
7 Days Ago | 0.91 | 1.08 | 4.01 | 4.36 |
30 Days Ago | 0.91 | 1.08 | 4.04 | 4.37 |
60 Days Ago | 0.90 | 1.07 | 4.03 | 4.38 |
90 Days Ago | 0.90 | 1.07 | 4.03 | 4.40 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.93 | 1.10 | 4.04 | 4.43 |
Zacks Consensus Estimate | 0.92 | 1.09 | 4.00 | 4.33 |
Earnings ESP | 0.54% | 0.92% | 0.94% | 2.35% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.96 | 0.98 | 1.15 | 0.79 | NA |
Estimate | 0.95 | 0.96 | 1.03 | 0.81 | NA |
Difference | 0.01 | 0.02 | 0.12 | -0.02 | 0.03 |
Surprise | 1.05% | 2.08% | 11.65% | -2.47% | 3.08% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more